These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15631868)

  • 1. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the plasma half-life of 11alpha-deuterium cortisol as a sensitive index for the analysis of human 11beta-HSD2 activity in vivo.
    Kasuya Y; Yokokawa A; Hamura K; Shibasaki H; Furuta T
    Steroids; 2005 Nov; 70(12):811-6. PubMed ID: 16005482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 11beta-HSD activities in vivo following oral administration of cortisol-13C4,2H1 to a human subject.
    Kasuya Y; Yokokawa A; Takayama S; Shibasaki H; Furuta T
    Steroids; 2003 Feb; 68(2):167-76. PubMed ID: 12606008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
    Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
    Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
    Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
    Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
    Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans.
    Sobieszczyk P; Borlaug BA; Gornik HL; Knauft WD; Beckman JA
    Clin Sci (Lond); 2010 Aug; 119(10):437-42. PubMed ID: 20515440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors.
    Kadereit B; Fustier P; Shojaati K; Frey BM; Frey FJ; Mohaupt MG
    J Am Soc Nephrol; 2005 Dec; 16(12):3507-16. PubMed ID: 16251242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
    Terao M; Itoi S; Murota H; Katayama I
    Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.
    Causevic M; Mohaupt M
    Mol Aspects Med; 2007 Apr; 28(2):220-6. PubMed ID: 17532462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
    Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.